Epigenome-based cancer risk prediction: rationale, opportunities and challenges

Windschwendter M, et al. (including Joly Y) "Epigenome-based cancer risk prediction: rationale, opportunities and challenges" 1:15 (2018) Nature Reviews Clinical Oncology, 292-309.

This content has been updated on May, 29 2018 at 10 h 14 min.